Sr. Director, US Team Lead, LORBRENA/BRAF Lung

Role: Lead marketing strategy and team management for Pfizer's US Precision Medicine Thoracic Franchise, focusing on biomarker-defined NSCLC therapies (LORBRENA and BRAFTOVI+MEKTOVI). Objectives: drive portfolio growth through AI-enabled, precision-targeted marketing and cross-functional leadership. Responsibilities: develop multi-year strategic vision, leverage machine learning and predictive analytics for customer engagement, coordinate with brand, medical, market access, and analytics teams, and oversee performance metrics and compliance. Qualifications: 12+ years pharma experience (advanced degrees preferred), proven expertise applying AI/data science to commercial marketing, and leadership of diverse marketing teams, with a track record in oncology, precision medicine, or biomarker-driven therapies. High-Value: oncology, NSCLC, biomarker-driven, AI-enabled marketing, US market, senior leadership engagement. WorkSetup: multiple US locations; domestic travel ~20%. The role demands strategic thinking, cross-functional collaboration, and a strong foundation in digital health tools, with an emphasis on innovation, compliance, and patient-centric outcomes.